MINAPHARM Pharmaceuticals (EGX:MIPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
351.23
+9.38 (2.74%)
At close: Dec 3, 2025
86.53%
Market Cap 4.04B
Revenue (ttm) 6.92B
Net Income (ttm) 156.33M
Shares Out 11.78M
EPS (ttm) 10.57
PE Ratio 32.46
Forward PE n/a
Dividend 2.50 (0.73%)
Ex-Dividend Date Aug 13, 2025
Volume 39,041
Average Volume 5,272
Open 341.85
Previous Close 341.85
Day's Range 335.05 - 398.50
52-Week Range 145.00 - 372.00
Beta -0.01
RSI 65.25
Earnings Date Dec 1, 2025

About MINAPHARM Pharmaceuticals

MINAPHARM Pharmaceuticals produces medicines, chemicals, medical and dental supplies, cosmetics, veterinary and herbal medicines, and dietary supplements in Egypt and internationally. It operates through Biological Production, Drug Production, and Other Pharmaceuticals segments. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and h... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 450
Stock Exchange Egyptian Stock Exchange
Ticker Symbol MIPH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.